Stock XOMAO XOMA CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Calendar XOMA Corporation Nasdaq

Equities

XOMAO

US98419J4040

Market Closed - Nasdaq
Other stock markets
 02:00:01 18/05/2024 am IST 		5-day change 1st Jan Change
25.1 USD 0.00% Intraday chart for XOMA Corporation -0.08% -0.08%
09/05 Earnings Flash (XOMA) XOMA CORPORATION Reports Q1 Revenue $1.5M MT
09/05 XOMA Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Chart calendar XOMA Corporation

ef.QTga6mugCJKew9oaOfA0UfHf5Rj4xCxR1rBkntzwVBQ.dw143xLwXMbdrbN1fpNmI4uM1Ei9iWcUj50s9q60YnMtUn3cANNMo8jz4g~574d8ba91bbdb9c8342481c84c571e13

Upcoming events on XOMA Corporation

20/05/2024 08:30 pm H.C. Wainwright Bioconnect Investor Conference
06/08/2024 Q2 2024 Earnings Release (Projected)
05/11/2024 Q3 2024 Earnings Release (Projected)
06/03/2025 Q4 2024 Earnings Release (Projected)
13/05/2025 Q1 2025 Earnings Release (Projected)

Past events on XOMA Corporation

15/05/2024 09:30 pm Annual General Meeting
09/05/2024 05:00 pm Q1 2024 Earnings Release
11/03/2024 08:10 pm Leerink Partners Global Biopharma Conference
08/03/2024 06:00 pm Q4 2023 Earnings Release
06/03/2024 09:00 pm TD Cowen Health Care Conference
07/11/2023 06:00 pm Q3 2023 Earnings Release
12/09/2023 07:00 pm H.C. Wainwright Global Investment Conference
08/08/2023 05:00 pm Q2 2023 Earnings Release
17/05/2023 09:30 pm Annual General Meeting
09/05/2023 05:00 pm Q1 2023 Earnings Release
02/05/2023 08:00 pm H.C. Wainwright BioConnect Investor Conference - Fireside Chat
09/03/2023 06:00 pm Q4 2022 Earnings Release
08/03/2023 12:40 am Cowen Health Care Conference
03/11/2022 05:00 pm Q3 2022 Earnings Release
12/09/2022 07:30 pm H.C. Wainwright Global Investment Conference
04/08/2022 05:00 pm Interim 2022 Earnings Release
25/05/2022 07:30 pm H.C. Wainwright Global Life Sciences Investment Conference
18/05/2022 09:30 pm Annual General Meeting
05/05/2022 05:00 pm Q1 2022 Earnings Release
17/03/2022 10:10 pm Oppenheimer Healthcare Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		18,4
21,2
-13.43%		29,4
18,9
55.27%		38,2
37,4
2.13%		6,03
5,60
7.63%		4,76
6,50
-26.8%
22,9

EBITDA
Million USD		Released
Forecast
Spread 		-3,86
-3,40
-13.53%		12,4
9,40
32.32%		17,5
17,7
-0.93%		-17,4
-29,9
41.78%		-40,9
-27,6
-48.36%
-18,7

EBIT
Million USD		Released
Forecast
Spread 		-3,89
-2,41
-61.05%		12,4
2,56
384.31%		17,5
18,0
-2.56%		-17,4
-22,8
23.45%		-41,8
-25,1
-67.06%
-7,00

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-1,98
-1,03
-91.56%		11,8
3,40
247.38%		15,9
15,1
5.56%		-17,1
-22,5
23.92%		-40,8
-23,6
-73.38%
-16,7

Net income
Million USD		Released
Forecast
Spread 		-1,98
-1,93
-2.45%		8,79
4,43
98.52%		7,79
12,5
-37.53%		-22,6
-22,5
-0.34%		-46,3
-26,3
-76.06%
-26,6

EPS
USD		Released
Forecast
Spread 		-0,23
-0,22
-4.55%		0,78
0,41
88.71%		0,65
1,02
-36.27%		-1,98
-1,97
-0.76%		-4,04
-2,05
-97.07%
-2,28

Announcement Date10/03/2010/03/2108/03/2209/03/2308/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		3,11
3,17
-1.83%		0,98
4,27
-76.98%		0,45
4,52
-90.02%		1,49
1,06
40.19%		0,44
0,77
-42.88%		1,66
0,80
107.25%		0,83
1,19
-29.96%		1,83
3,61
-49.15%		1,49
1,34
11.47%
8,85


5,80


6,70

EBITDA
Million USD		Released
Forecast
Spread 		-2,06
-2,30
10.3%		-4,77
3,20
-248.94%		-4,37
3,60
-221.33%		-6,21
-18,7
66.79%		-9,94
-5,40
-84.15%		-5,73
-4,80
-19.42%		-5,56
-4,40
-26.43%		-19,7
-5,70
-245.77%		-7,00
-5,30
-32.11%
-5,00


-4,60


-3,80

EBIT
Million USD		Released
Forecast
Spread 		-2,07
-5,15
59.93%		-4,77
-3,07
-55.33%		-4,37
-3,52
-24.17%		-6,21
-4,40
-41.14%		-10,2
-5,00
-103.4%		-5,96
-5,00
-19.14%		-5,79
-4,90
-18.1%		-19,9
-0,60
-3222.33%		-7,00
-4,95
-41.49%
1,50


-1,50


0,10

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-2,28
-5,35
57.41%		-4,67
-1,05
-344.34%		-4,18
-1,05
-298.92%		-5,99
-11,4
47.45%		-9,81
-5,05
-94.32%		-5,40
-4,70
-14.89%		-5,51
-4,20
-31.17%		-20,1
-2,80
-618.18%		-8,60
-7,80
-10.19%
-1,30


-4,20


-2,50

Net income
Million USD		Released
Forecast
Spread 		-3,65
-6,04
39.57%		-6,04
-1,51
-300.66%		-5,55
-2,40
-130.76%		-7,34
-5,40
-36%		-11,2
-5,70
-96.16%		-6,77
-6,00
-12.8%		-6,88
-5,50
-25.04%		-21,5
-4,15
-417.52%		-9,96
-9,40
-5.99%
-4,60


-6,80


-5,55

EPS
USD		Released
Forecast
Spread 		-0,32
-0,53
39.62%		-0,53
-0,16
-224.5%		-0,48
-0,23
-108.7%		-0,64
-1,11
42.34%		-0,98
-0,50
-97.98%		-0,59
-0,52
-13.46%		-0,60
-0,48
-25%		-1,87
-0,36
-419.44%		-0,86
-0,81
-6.17%
-0,40


-0,58


-0,47

Announcement Date05/05/2204/08/2203/11/2209/03/2309/05/2308/08/2307/11/2308/03/2409/05/24---

Upcoming sector events for XOMA Corporation

24/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
25/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 10:30 am ARGENX SE: Q2 2024 Earnings Release
30/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for XOMA Corporation

17/05/2024 04:30 pm AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 05:16 pm BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 10:30 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
15/05/2024 05:35 pm THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
15/05/2024 04:30 pm CABALETTA BIO, INC.: Q1 2024 Earnings Release
15/05/2024 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
16/05/2024 01:31 am CELCUITY INC.: Q1 2024 Earnings Release
15/05/2024 01:35 am ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
15/05/2024 01:30 am ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 05:30 pm IMMUNOME, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. XOMA Stock
  4. XOMAO Stock
  5. Calendar XOMA Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW